Format
Sort by
Items per page

Send to

Choose Destination

Best matches for safety AND transfusion - action:

Search results

Items: 1 to 20 of 112

  • The following term was ignored: -
  • See the search details.
1.

Blood derived eye drops for the treatment of cornea and ocular surface diseases.

Giannaccare G, Versura P, Buzzi M, Primavera L, Pellegrini M, Campos EC.

Transfus Apher Sci. 2017 Aug;56(4):595-604. doi: 10.1016/j.transci.2017.07.023. Epub 2017 Aug 8. Review.

PMID:
28844373
2.

Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles.

Reiner AT, Witwer KW, van Balkom BWM, de Beer J, Brodie C, Corteling RL, Gabrielsson S, Gimona M, Ibrahim AG, de Kleijn D, Lai CP, Lötvall J, Del Portillo HA, Reischl IG, Riazifar M, Salomon C, Tahara H, Toh WS, Wauben MHM, Yang VK, Yang Y, Yeo RWY, Yin H, Giebel B, Rohde E, Lim SK.

Stem Cells Transl Med. 2017 Aug;6(8):1730-1739. doi: 10.1002/sctm.17-0055. Epub 2017 Jul 17. Review.

3.

Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity.

Bhansali S, Dutta P, Yadav MK, Jain A, Mudaliar S, Hawkins M, Kurpad AV, Pahwa D, Yadav AK, Sharma RR, Jha V, Marwaha N, Bhansali S, Bhansali A.

Diabetol Metab Syndr. 2017 Jul 4;9:50. doi: 10.1186/s13098-017-0248-7. eCollection 2017.

4.

Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.

Gimona M, Pachler K, Laner-Plamberger S, Schallmoser K, Rohde E.

Int J Mol Sci. 2017 Jun 3;18(6). pii: E1190. doi: 10.3390/ijms18061190.

5.

Homologous platelet-rich plasma for the treatment of knee involvement in primary Sjögren’s syndrome.

Bottegoni C, Farinelli L, Aquili A, Chiurazzi E, Gigante A.

J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4 Suppl 1):63-67.

PMID:
28002901
6.

Reversal of direct oral anticoagulants: a practical approach.

Shih AW, Crowther MA.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):612-619. Review.

PMID:
27913536
7.

Efficacy of Azacitidine in the treatment of adult patients aged 65 years or older with AML.

Tenti E, Papayannidis C, Marconi G, Parisi S, Simonetti G, Paolini S, Sartor C, Ottaviani E, Testoni N, Martinelli G.

Expert Opin Pharmacother. 2016 Dec;17(18):2479-2486. Epub 2016 Nov 21. Review.

PMID:
27829292
8.
9.

The safety of pharmacologic options for the treatment of persons with hemophilia.

Franchini M, Mannucci PM.

Expert Opin Drug Saf. 2016 Oct;15(10):1391-400. doi: 10.1080/14740338.2016.1208747. Epub 2016 Jul 18. Review.

PMID:
27367551
10.

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients.

Polivkova V, Rohon P, Klamova H, Cerna O, Divoka M, Curik N, Zach J, Novak M, Marinov I, Soverini S, Faber E, Machova Polakova K.

PLoS One. 2016 May 23;11(5):e0155959. doi: 10.1371/journal.pone.0155959. eCollection 2016.

11.

Minimizing Blood Loss in Orthopaedic Surgery The Role of Antifibrinolytics.

Lerman DM, Rapp TB.

Bull Hosp Jt Dis (2013). 2015 Jun;73(2):83-9. Review.

PMID:
26517160
12.

Dengue viremia in blood donors in Northern India: Challenges of emerging dengue outbreaks to blood transfusion safety.

Mangwana S.

Asian J Transfus Sci. 2015 Jul-Dec;9(2):177-80. doi: 10.4103/0973-6247.154253.

13.

The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis.

McMullin MF, Harrison CN, Niederwieser D, Demuynck H, Jäkel N, Gopalakrishna P, McQuitty M, Stalbovskaya V, Recher C, Theunissen K, Gisslinger H, Kiladjian JJ, Al-Ali HK.

Exp Hematol Oncol. 2015 Sep 15;4:26. doi: 10.1186/s40164-015-0021-2. eCollection 2015.

14.

Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash.

Weiss L, Gary D, Swern AS, Freeman J, Sugrue MM.

Ther Clin Risk Manag. 2015 Sep 4;11:1355-60. doi: 10.2147/TCRM.S86449. eCollection 2015.

15.

Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis?

Samoš M, Fedor M, Kovář F, Duraj L, Stančiaková L, Galajda P, Staško J, Kubisz P, Mokáň M.

Blood Coagul Fibrinolysis. 2016 Mar;27(2):117-20. doi: 10.1097/MBC.0000000000000406. Review.

PMID:
26340464
16.

Hemin activation of innate cellular response blocks human immunodeficiency virus type-1-induced osteoclastogenesis.

Takeda K, Adhikari R, Yamada KM, Dhawan S.

Biochem Biophys Res Commun. 2015 Aug 14;464(1):7-12. doi: 10.1016/j.bbrc.2015.05.037. Epub 2015 May 19.

17.

Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays.

Bordeleau S, Poitras J, Marceau D, Breton C, Beaupré P, Archambault PM.

BMC Health Serv Res. 2015 Mar 15;15:106. doi: 10.1186/s12913-015-0775-6.

18.

[The support of immune safety of hemotransfusions under implementation of cardiosurgery operations].

Fanaskova EV, Gruzdeva OV, Goncharenko MV, Moiseenkov GV, Grigor'ev EV.

Klin Lab Diagn. 2014 Dec;59(12):40-4. Russian.

PMID:
25872268
19.

Proactive risk assessment of blood transfusion process, in pediatric emergency, using the Health Care Failure Mode and Effects Analysis (HFMEA).

Dehnavieh R, Ebrahimipour H, Molavi-Taleghani Y, Vafaee-Najar A, Noori Hekmat S, Esmailzdeh H.

Glob J Health Sci. 2014 Dec 25;7(1):322-31. doi: 10.5539/gjhs.v7n1p322.

20.

Extracorporeal photopheresis as a therapy for autoimmune diseases.

Kuzmina Z, Stroncek D, Pavletic SZ.

J Clin Apher. 2015 Aug;30(4):224-37. doi: 10.1002/jca.21367. Epub 2014 Dec 26. Review.

PMID:
25546289

Supplemental Content

Loading ...
Support Center